Jeff Scherer, PharmD, MPH, BCPS, BCGP: No financial relationships to disclose
Alzheimer’s therapies have been known to cause a variety of side effects while aiming to keep the disease at bay. This session with discuss efficacy and safety around the newest therapies and other updates with Alzheimer’s disease.
Learning Objectives:
Differentiate between current and newly approved medications for Alzheimer's disease with regards to efficacy and safety.
Discuss proposed future practice innovation and payments in medication management with Alzheimer’s disease.
Given a patient case, select the most appropriate pharmacotherapy option for patients with Alzheimer’s disease.
